185 results
6-K
APTO
Aptose Biosciences Inc
19 Sep 05
Current report (foreign)
12:00am
-- Program continuing with no safety concerns from interim assessment --
TSX: LOR
AMEX: LRP
TORONTO, CANADA, September 13, 2005 –Lorus Therapeutics Inc … for the management of cancer, today announced a steering committee assessment of progress in its program of six U.S. National Cancer Institute (NCI)-sponsored
6-K
EX-99.1
APTO
Aptose Biosciences Inc
10 Oct 07
Current report (foreign)
12:00am
included: (i) an assessment of a stream of economic earnings or cash flows that can be properly attributed to the Subject Property during a finite … future period; (ii) an assessment of an appropriate discount factor to be used to convert the future cash flow stream into a capital sum; and (iii
6-K/A
EX-99.5
APTO
Aptose Biosciences Inc
27 Sep 12
Animal Rights License Agreement
12:00am
Taxes or relating to the statutory period within which an assessment, reassessment, or other proceeding in respect of prior fiscal periods may be issued … in effect until the first date on which no assessment, reassessment or other document assessing liability for tax claimed or penalties may be issued
6-K
EX-99.4
APTO
Aptose Biosciences Inc
12 Mar 04
Current report (foreign)
12:00am
in combination with the anticancer agent capecitabine.
To date, data have been collected on 21 patients evaluable for tumor assessment.
One patient … assessment of tumor responses will be completed and a final independent
review of results will occur following conclusion of the study
6-K
iqdswnxnzbgvuupkh uc
11 Oct 05
Current report (foreign)
12:00am
6-K
EX-99.3
g01wprf
1 Sep 06
Lorus Therapeutics Form 6-K
12:00am
8-K
EX-99.1
u5avfmc 27p0
19 Jul 22
Financial Statements and Exhibits
5:53pm
6-K
EX-99.2
fvfj4eptrovg6wgte9
20 Apr 09
Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2009
12:00am
6-K/A
EX-99.2
qgvlcxvd
27 Sep 12
Animal Rights License Agreement
12:00am
6-K
EX-99.2
nsqbshhuo
1 Sep 06
Lorus Therapeutics Form 6-K
12:00am
6-K
EX-99.1
q4uwoqdo7n590m0z
14 Oct 08
Current report (foreign)
12:00am
6-K
EX-99.1
ncaxmhr 77oqz7gj8
14 Jan 09
Current report (foreign)
12:00am
6-K
EX-99.1
zki2g
1 Sep 06
Lorus Therapeutics Form 6-K
12:00am
6-K
tojapefq
22 Mar 05
Current report (foreign)
12:00am
6-K
EX-99
3pny7738
14 Oct 04
Current report (foreign)
12:00am
6-K/A
EX-99
wymm1
23 Mar 05
Current report (foreign) (amended)
12:00am
6-K/A
EX-99
ieb3nbi
23 Mar 05
Current report (foreign) (amended)
12:00am
6-K
EX-99.2
h8w0fua 6b5mhk
30 May 07
Current report (foreign)
12:00am
6-K
EX-99
sgxdz3m44lp
14 Oct 04
Current report (foreign)
12:00am